Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Rapid Response Innovation Awards, 2009
    Development of Potent Conformation-Specific Compounds Directed to Monomeric Alpha-Synuclein

    Promising Outcomes of Original Grant:
    The goal of our original funded grant was to use our alpha-synuclein assay to identify compounds that prevent conformational change to the fully open form of the...

  • Rapid Response Innovation Awards, 2009
    Evaluation of a Viral Non-coding RNA as a Neuroprotective and Neurorestorative Therapy in Chronic Models of Parkinson's Disease

    Promising Outcomes of Original Grant:
    Previously, we asked whether a novel viral non-coding RNA (an RNA which does not appear to encode a protein), but with known pro-life functions, could act to...

  • MJFF Research Grant, 2009
    N-Acetylcysteine CSF Levels and Biomarkers in a Pre-clinical Model of PD

    Objective/Rationale:
    N-Acetylcysteine (NAC) is an orally absorbed compound that supports neuronal synthesis of glutathione, a key neuronal antioxidant.  Our objective here is to establish the blood and...

  • Rapid Response Innovation Awards, 2009
    Generation of Dorsal Motor Nucleus (DMN) Specific Pre-clinical Model of Alpha-Synuclein Overexpression to Study Etiology of Autonomic Dysfunction in PD

    Promising Outcomes of Original Grant:
    According to Braak Staging of PD Pathology, the dorsal motor nucleus (DMN) is one of the earliest brain nuclei that accumulate alpha-Synuclein (aSyn) pathology...

  • MJFF Research Grant, 2009
    Neoangiogenesis and blood-brain barrier in L-DOPA-induced dyskinesia

    Promising Outcomes of Original Grant:
    Working on a pre-clinical model of Parkinson´s disease, we have found that levodopa treatment induces proliferation of endothelial cells and angiogenesis in the...

  • MJFF Research Grant, 2009
    Specific Inhibition of Nucleation of Alpha-Synuclein Aggregation as a Therapeutic Strategy

    The discovery of specific genes associated with rare, genetic forms of Parkinson’s disease has opened the opportunity to investigate the mechanisms of the disease and to develop novel drugs. Parkinson...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.